Forman Mark S
CIK 0001922353
Chief Medical Officer
Filings
11
Latest Mar 4, 2026
Issuers covered
2
Showing
11 of 11
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 0% | -17.0% | -17.0% | -7.7% | -26.3% |
| 90 days | 2 | 0% | -50.8% | -50.8% | -49.5% | -52.1% |
| 180 days | 2 | 100% | +10.9% | +10.9% | +20.0% | +1.8% |
| 365 days | 2 | 100% | +27.7% | +27.7% | +47.6% | +7.9% |
Issuers
Companies where Forman Mark S has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PASG | Passage Bio, Inc. | 6 | Mar 19, 2024 |
| VTYX | Ventyx Biosciences, Inc. | 5 | Mar 4, 2026 |
All filings
11 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|